

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | oligosaccharide catabolic process (GO:0009313) | 8.30922337 |
| 2 | glycosphingolipid catabolic process (GO:0046479) | 8.21151511 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.54258990 |
| 4 | glycolipid catabolic process (GO:0019377) | 7.41187571 |
| 5 | ceramide catabolic process (GO:0046514) | 6.67178649 |
| 6 | amino sugar catabolic process (GO:0046348) | 6.57954420 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 6.37621774 |
| 8 | * positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 6.04583573 |
| 9 | regulation of cholesterol storage (GO:0010885) | 5.87340112 |
| 10 | glucosamine-containing compound catabolic process (GO:1901072) | 5.73166008 |
| 11 | cellular response to thyroid hormone stimulus (GO:0097067) | 5.48908268 |
| 12 | cellular extravasation (GO:0045123) | 5.12101650 |
| 13 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.97927058 |
| 14 | response to peptidoglycan (GO:0032494) | 4.96922956 |
| 15 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.86192419 |
| 16 | respiratory burst (GO:0045730) | 4.79540378 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.75616470 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.75616470 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.75616470 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.75616470 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.75616470 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.75616470 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 4.71590416 |
| 24 | sphingolipid catabolic process (GO:0030149) | 4.64661814 |
| 25 | membrane lipid catabolic process (GO:0046466) | 4.61430466 |
| 26 | granulocyte activation (GO:0036230) | 4.58087002 |
| 27 | superoxide anion generation (GO:0042554) | 4.49911809 |
| 28 | * osteoclast differentiation (GO:0030316) | 4.45112268 |
| 29 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.41492709 |
| 30 | apoptotic cell clearance (GO:0043277) | 4.40934793 |
| 31 | response to thyroid hormone (GO:0097066) | 4.39882987 |
| 32 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.35522607 |
| 33 | ganglioside metabolic process (GO:0001573) | 4.32608972 |
| 34 | reactive oxygen species biosynthetic process (GO:1903409) | 4.29185109 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 4.28268133 |
| 36 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.27822189 |
| 37 | defense response to protozoan (GO:0042832) | 4.26749281 |
| 38 | neutrophil activation (GO:0042119) | 4.26333311 |
| 39 | positive regulation of interferon-alpha production (GO:0032727) | 4.24121069 |
| 40 | regulation of activation of Janus kinase activity (GO:0010533) | 4.22661014 |
| 41 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.18316432 |
| 42 | positive regulation of osteoclast differentiation (GO:0045672) | 4.17975713 |
| 43 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.17435733 |
| 44 | * regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 4.13254620 |
| 45 | cellular response to zinc ion (GO:0071294) | 4.08499501 |
| 46 | negative regulation of interleukin-17 production (GO:0032700) | 4.07233638 |
| 47 | T-helper 1 type immune response (GO:0042088) | 4.04590942 |
| 48 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 4.01296214 |
| 49 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.01018581 |
| 50 | positive regulation of mast cell degranulation (GO:0043306) | 4.01018581 |
| 51 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 4.00337201 |
| 52 | positive regulation of mast cell activation (GO:0033005) | 3.99036974 |
| 53 | regulation of interferon-alpha production (GO:0032647) | 3.97814012 |
| 54 | regulation of chemokine biosynthetic process (GO:0045073) | 3.93990751 |
| 55 | eosinophil chemotaxis (GO:0048245) | 3.93006100 |
| 56 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.92531043 |
| 57 | wound healing, spreading of epidermal cells (GO:0035313) | 3.91788327 |
| 58 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.89520308 |
| 59 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.88478462 |
| 60 | regulation of monocyte chemotaxis (GO:0090025) | 3.84724335 |
| 61 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.84069260 |
| 62 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.83790094 |
| 63 | barbed-end actin filament capping (GO:0051016) | 3.81214308 |
| 64 | negative regulation of interleukin-12 production (GO:0032695) | 3.74512784 |
| 65 | natural killer cell mediated immunity (GO:0002228) | 3.74092388 |
| 66 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.74092388 |
| 67 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.71257346 |
| 68 | monocyte chemotaxis (GO:0002548) | 3.70168086 |
| 69 | peptide catabolic process (GO:0043171) | 3.68824876 |
| 70 | keratan sulfate catabolic process (GO:0042340) | 3.66942073 |
| 71 | myeloid cell activation involved in immune response (GO:0002275) | 3.64181163 |
| 72 | positive regulation of type 2 immune response (GO:0002830) | 3.61482628 |
| 73 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.58740751 |
| 74 | * positive regulation of bone remodeling (GO:0046852) | 3.58702262 |
| 75 | * positive regulation of bone resorption (GO:0045780) | 3.58702262 |
| 76 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.56075083 |
| 77 | response to protozoan (GO:0001562) | 3.56031182 |
| 78 | decidualization (GO:0046697) | 3.54227086 |
| 79 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.53306803 |
| 80 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.49531243 |
| 81 | transferrin transport (GO:0033572) | 3.48490783 |
| 82 | regulation of mononuclear cell migration (GO:0071675) | 3.48452212 |
| 83 | eosinophil migration (GO:0072677) | 3.47898643 |
| 84 | intracellular pH reduction (GO:0051452) | 3.47273174 |
| 85 | positive regulation of interleukin-12 production (GO:0032735) | 3.45242844 |
| 86 | phagocytosis, recognition (GO:0006910) | 3.44654678 |
| 87 | B cell mediated immunity (GO:0019724) | 3.42716909 |
| 88 | leukocyte mediated cytotoxicity (GO:0001909) | 3.39171474 |
| 89 | response to muramyl dipeptide (GO:0032495) | 3.38993020 |
| 90 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.38595603 |
| 91 | lymphocyte chemotaxis (GO:0048247) | 3.36699583 |
| 92 | macrophage differentiation (GO:0030225) | 3.34860741 |
| 93 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.34292661 |
| 94 | pinocytosis (GO:0006907) | 3.34173140 |
| 95 | iron ion import (GO:0097286) | 3.31793245 |
| 96 | N-acetylneuraminate metabolic process (GO:0006054) | 3.31755603 |
| 97 | pH reduction (GO:0045851) | 3.31580206 |
| 98 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.30721676 |
| 99 | positive regulation of cholesterol efflux (GO:0010875) | 3.28463138 |
| 100 | phagosome maturation (GO:0090382) | 3.25278877 |
| 101 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.25150187 |
| 102 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.22833620 |
| 103 | granulocyte chemotaxis (GO:0071621) | 3.22034498 |
| 104 | regulation of mast cell degranulation (GO:0043304) | 3.21978474 |
| 105 | ferric iron transport (GO:0015682) | 3.21034068 |
| 106 | trivalent inorganic cation transport (GO:0072512) | 3.21034068 |
| 107 | leukocyte aggregation (GO:0070486) | 3.20699355 |
| 108 | positive regulation of interleukin-10 production (GO:0032733) | 3.18856376 |
| 109 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.18444354 |
| 110 | response to host immune response (GO:0052572) | 3.18444354 |
| 111 | regulation of superoxide anion generation (GO:0032928) | 3.18083892 |
| 112 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.17503191 |
| 113 | positive regulation of macrophage cytokine production (GO:0060907) | 3.16261900 |
| 114 | positive regulation of heat generation (GO:0031652) | 3.15503391 |
| 115 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.14613585 |
| 116 | negative regulation of lipid storage (GO:0010888) | 3.14445387 |
| 117 | protein localization to endosome (GO:0036010) | 3.14395405 |
| 118 | microglial cell activation (GO:0001774) | 3.13384006 |
| 119 | neutrophil chemotaxis (GO:0030593) | 3.12549485 |
| 120 | positive regulation of leukocyte degranulation (GO:0043302) | 3.12388557 |
| 121 | positive regulation of interferon-beta production (GO:0032728) | 3.12326202 |
| 122 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.12270341 |
| 123 | positive regulation of macrophage differentiation (GO:0045651) | 3.11677695 |
| 124 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.11572466 |
| 125 | low-density lipoprotein particle remodeling (GO:0034374) | 3.10945231 |
| 126 | regulation of mast cell activation (GO:0033003) | 3.10796511 |
| 127 | macrophage activation (GO:0042116) | 3.10576391 |
| 128 | regulation of fever generation (GO:0031620) | 3.10181132 |
| 129 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.10099618 |
| 130 | detection of molecule of bacterial origin (GO:0032490) | 3.10014409 |
| 131 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.09643400 |
| 132 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.09427632 |
| 133 | granulocyte migration (GO:0097530) | 3.08448042 |
| 134 | positive regulation of lymphocyte migration (GO:2000403) | 3.07211724 |
| 135 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.05174628 |
| 136 | regulation of interleukin-17 production (GO:0032660) | 3.04876583 |
| 137 | neutrophil migration (GO:1990266) | 3.04310722 |
| 138 | response to lipoprotein particle (GO:0055094) | 3.04299047 |
| 139 | T cell migration (GO:0072678) | 3.02709331 |
| 140 | regulation of leukocyte degranulation (GO:0043300) | 3.02183735 |
| 141 | neutrophil mediated immunity (GO:0002446) | 3.00358771 |
| 142 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.99889391 |
| 143 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99406710 |
| 144 | vitamin D metabolic process (GO:0042359) | 2.98370660 |
| 145 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.97934405 |
| 146 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.97440701 |
| 147 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.96652020 |
| 148 | positive regulation of interleukin-17 production (GO:0032740) | 2.95831661 |
| 149 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.95462693 |
| 150 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.95433490 |
| 151 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.94613004 |
| 152 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.94613004 |
| 153 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.94604577 |
| 154 | positive regulation of interleukin-2 production (GO:0032743) | 2.92992849 |
| 155 | plasma lipoprotein particle clearance (GO:0034381) | 2.92567553 |
| 156 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.90279038 |
| 157 | regulation of hypersensitivity (GO:0002883) | 2.89250193 |
| 158 | positive regulation of T cell cytokine production (GO:0002726) | 2.89126979 |
| 159 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.88752757 |
| 160 | positive regulation of interleukin-6 production (GO:0032755) | 2.87722530 |
| 161 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.83912148 |
| 162 | positive regulation of sterol transport (GO:0032373) | 2.81914354 |
| 163 | positive regulation of cholesterol transport (GO:0032376) | 2.81914354 |
| 164 | positive regulation of antigen processing and presentation (GO:0002579) | 2.78336078 |
| 165 | regulation of cholesterol esterification (GO:0010872) | 2.76965063 |
| 166 | lytic vacuole organization (GO:0080171) | 2.75743773 |
| 167 | lysosome organization (GO:0007040) | 2.75743773 |
| 168 | phospholipid efflux (GO:0033700) | 2.73964651 |
| 169 | glucose 6-phosphate metabolic process (GO:0051156) | 2.71830057 |
| 170 | regulation of macrophage chemotaxis (GO:0010758) | 2.71671081 |
| 171 | iron ion transport (GO:0006826) | 2.71591755 |
| 172 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.69864255 |
| 173 | * positive regulation of tissue remodeling (GO:0034105) | 2.68905851 |
| 174 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.68779695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.75087309 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.67409808 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.42586712 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.70771303 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.43439602 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.22545458 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.11314149 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.78432313 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.75149011 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 3.56327902 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.27124766 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.20737706 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.07620499 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.86095401 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.77967254 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.77806987 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70331700 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.60783216 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.47865836 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.39944728 |
| 21 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.00907320 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.97344027 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97024490 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.95495393 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90861664 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.90603839 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.86904513 |
| 28 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.86021124 |
| 29 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.80522808 |
| 30 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.77713253 |
| 31 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.67657797 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56928977 |
| 33 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.55828365 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53855984 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47016126 |
| 36 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44750810 |
| 37 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.44135145 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41688481 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.39903991 |
| 40 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.39148437 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.39148437 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.38842173 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36876149 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34681034 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34488703 |
| 46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30969267 |
| 47 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.30285749 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26792291 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26490919 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21112848 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20456823 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17697552 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17439682 |
| 54 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16859662 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15254027 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15060593 |
| 57 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14381161 |
| 58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13904942 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13241989 |
| 60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10665683 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.09027269 |
| 62 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07970964 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07074407 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04929685 |
| 65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02859096 |
| 66 | MAF_26560356_Chip-Seq_TH1_Human | 1.01317342 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00741257 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00239269 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99761825 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99691501 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98238462 |
| 72 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.96472126 |
| 73 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95353593 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94890368 |
| 75 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.94126794 |
| 76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93515705 |
| 77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.93388895 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89427083 |
| 79 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89062563 |
| 80 | MYB_26560356_Chip-Seq_TH1_Human | 0.89022172 |
| 81 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88064563 |
| 82 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87840187 |
| 83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.87567123 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87449129 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86499991 |
| 86 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85820314 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85315681 |
| 88 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.84631612 |
| 89 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.83926611 |
| 90 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.83763146 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83692497 |
| 92 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81515479 |
| 93 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80824356 |
| 94 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79480351 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79435003 |
| 96 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79063369 |
| 97 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.77932430 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77478018 |
| 99 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.77468599 |
| 100 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.77366325 |
| 101 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.76640539 |
| 102 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.76595488 |
| 103 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76332169 |
| 104 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75363262 |
| 105 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.72791588 |
| 106 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.72791588 |
| 107 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72615843 |
| 108 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70901458 |
| 109 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.67305258 |
| 110 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.66476892 |
| 111 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.65554171 |
| 112 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.65021455 |
| 113 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.63696085 |
| 114 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.62909378 |
| 115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.62497501 |
| 116 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.62466419 |
| 117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.61031569 |
| 118 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.60599847 |
| 119 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.58633818 |
| 120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58357624 |
| 121 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.56037542 |
| 122 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.55642920 |
| 123 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.53962292 |
| 124 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.51663579 |
| 125 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.48163389 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.47806634 |
| 127 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.47506606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.42430407 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 4.41676075 |
| 3 | MP0009785_altered_susceptibility_to | 4.40308725 |
| 4 | MP0003436_decreased_susceptibility_to | 4.32777638 |
| 5 | MP0006082_CNS_inflammation | 3.80276090 |
| 6 | MP0002419_abnormal_innate_immunity | 3.58854710 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.49268963 |
| 8 | MP0003303_peritoneal_inflammation | 3.43643048 |
| 9 | MP0005025_abnormal_response_to | 3.34072565 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 3.29003694 |
| 11 | MP0003329_amyloid_beta_deposits | 3.07630266 |
| 12 | MP0003724_increased_susceptibility_to | 3.04608045 |
| 13 | MP0005671_abnormal_response_to | 3.02880806 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.76638998 |
| 15 | MP0002723_abnormal_immune_serum | 2.55215214 |
| 16 | MP0005387_immune_system_phenotype | 2.48352396 |
| 17 | MP0001790_abnormal_immune_system | 2.48352396 |
| 18 | MP0000685_abnormal_immune_system | 2.46036830 |
| 19 | MP0004510_myositis | 2.39837090 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 2.35660656 |
| 21 | MP0001853_heart_inflammation | 2.33846201 |
| 22 | MP0001800_abnormal_humoral_immune | 2.29528346 |
| 23 | MP0009764_decreased_sensitivity_to | 2.26601374 |
| 24 | MP0001819_abnormal_immune_cell | 2.26137563 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.19858226 |
| 26 | MP0005058_abnormal_lysosome_morphology | 2.10528042 |
| 27 | MP0003448_altered_tumor_morphology | 2.04345918 |
| 28 | MP0002405_respiratory_system_inflammati | 2.03715999 |
| 29 | MP0001533_abnormal_skeleton_physiology | 2.03287771 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.95425571 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.94755093 |
| 32 | MP0005166_decreased_susceptibility_to | 1.90696873 |
| 33 | MP0003075_altered_response_to | 1.90403070 |
| 34 | MP0000343_altered_response_to | 1.85766530 |
| 35 | MP0005365_abnormal_bile_salt | 1.77590572 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.75793763 |
| 37 | MP0008469_abnormal_protein_level | 1.72365217 |
| 38 | MP0002006_tumorigenesis | 1.72229644 |
| 39 | MP0004947_skin_inflammation | 1.71191731 |
| 40 | MP0005310_abnormal_salivary_gland | 1.70117081 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.68716029 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.66094686 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.64117891 |
| 44 | MP0003690_abnormal_glial_cell | 1.61573259 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.58122119 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.55002070 |
| 47 | MP0003186_abnormal_redox_activity | 1.54316055 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.52392290 |
| 49 | MP0000716_abnormal_immune_system | 1.46891864 |
| 50 | MP0000858_altered_metastatic_potential | 1.43305639 |
| 51 | MP0000604_amyloidosis | 1.33707500 |
| 52 | MP0000569_abnormal_digit_pigmentation | 1.32219038 |
| 53 | MP0004782_abnormal_surfactant_physiolog | 1.32119898 |
| 54 | MP0005647_abnormal_sex_gland | 1.29977272 |
| 55 | MP0010386_abnormal_urinary_bladder | 1.27278004 |
| 56 | MP0001727_abnormal_embryo_implantation | 1.25025521 |
| 57 | MP0005164_abnormal_response_to | 1.24357626 |
| 58 | MP0002398_abnormal_bone_marrow | 1.24242695 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.20933963 |
| 60 | MP0003632_abnormal_nervous_system | 1.19468075 |
| 61 | MP0003828_pulmonary_edema | 1.18784351 |
| 62 | MP0002429_abnormal_blood_cell | 1.11161296 |
| 63 | MP0005451_abnormal_body_composition | 1.05376203 |
| 64 | MP0009763_increased_sensitivity_to | 1.03573568 |
| 65 | MP0001545_abnormal_hematopoietic_system | 1.01951740 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.01951740 |
| 67 | MP0003634_abnormal_glial_cell | 1.01788055 |
| 68 | MP0004019_abnormal_vitamin_homeostasis | 0.99436647 |
| 69 | MP0008260_abnormal_autophagy | 0.95286679 |
| 70 | MP0005390_skeleton_phenotype | 0.95140294 |
| 71 | MP0000689_abnormal_spleen_morphology | 0.93610200 |
| 72 | MP0000681_abnormal_thyroid_gland | 0.93429566 |
| 73 | MP0002722_abnormal_immune_system | 0.89884909 |
| 74 | MP0005174_abnormal_tail_pigmentation | 0.88755620 |
| 75 | MP0003195_calcinosis | 0.88260230 |
| 76 | MP0000920_abnormal_myelination | 0.87419190 |
| 77 | MP0003879_abnormal_hair_cell | 0.85357651 |
| 78 | MP0001851_eye_inflammation | 0.85304307 |
| 79 | MP0009278_abnormal_bone_marrow | 0.84300256 |
| 80 | MP0010307_abnormal_tumor_latency | 0.81964213 |
| 81 | MP0002254_reproductive_system_inflammat | 0.81470034 |
| 82 | MP0010234_abnormal_vibrissa_follicle | 0.80998994 |
| 83 | MP0004883_abnormal_blood_vessel | 0.79682939 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 0.78583748 |
| 85 | MP0008875_abnormal_xenobiotic_pharmacok | 0.77663586 |
| 86 | MP0005165_increased_susceptibility_to | 0.75957412 |
| 87 | MP0002090_abnormal_vision | 0.75922856 |
| 88 | MP0000249_abnormal_blood_vessel | 0.74596893 |
| 89 | MP0003631_nervous_system_phenotype | 0.74217970 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.73841744 |
| 91 | MP0000015_abnormal_ear_pigmentation | 0.73647857 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.73597115 |
| 93 | MP0000371_diluted_coat_color | 0.72593520 |
| 94 | MP0005257_abnormal_intraocular_pressure | 0.71300855 |
| 95 | MP0000372_irregular_coat_pigmentation | 0.71084883 |
| 96 | MP0002933_joint_inflammation | 0.70680582 |
| 97 | MP0002896_abnormal_bone_mineralization | 0.69293004 |
| 98 | MP0003279_aneurysm | 0.68384320 |
| 99 | MP0004742_abnormal_vestibular_system | 0.67624438 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.67103965 |
| 101 | MP0003633_abnormal_nervous_system | 0.66947294 |
| 102 | MP0009115_abnormal_fat_cell | 0.66904863 |
| 103 | MP0010329_abnormal_lipoprotein_level | 0.66893836 |
| 104 | MP0003795_abnormal_bone_structure | 0.65108239 |
| 105 | MP0002277_abnormal_respiratory_mucosa | 0.65064109 |
| 106 | MP0003950_abnormal_plasma_membrane | 0.64511250 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.63756061 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.63392805 |
| 109 | MP0010352_gastrointestinal_tract_polyps | 0.62377155 |
| 110 | MP0006054_spinal_hemorrhage | 0.60840095 |
| 111 | MP0000465_gastrointestinal_hemorrhage | 0.60492078 |
| 112 | MP0005076_abnormal_cell_differentiation | 0.60005080 |
| 113 | MP0000609_abnormal_liver_physiology | 0.58756732 |
| 114 | MP0003705_abnormal_hypodermis_morpholog | 0.58741088 |
| 115 | MP0002332_abnormal_exercise_endurance | 0.56601812 |
| 116 | MP0002295_abnormal_pulmonary_circulatio | 0.56189406 |
| 117 | MP0003091_abnormal_cell_migration | 0.55897420 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.54752288 |
| 119 | MP0001663_abnormal_digestive_system | 0.54716138 |
| 120 | MP0002138_abnormal_hepatobiliary_system | 0.54671657 |
| 121 | MP0005535_abnormal_body_temperature | 0.53213020 |
| 122 | MP0005171_absent_coat_pigmentation | 0.52018955 |
| 123 | MP0009840_abnormal_foam_cell | 0.51977261 |
| 124 | MP0003866_abnormal_defecation | 0.49665617 |
| 125 | MP0004130_abnormal_muscle_cell | 0.48765326 |
| 126 | MP0008873_increased_physiological_sensi | 0.47615986 |
| 127 | MP0005319_abnormal_enzyme/_coenzyme | 0.43813685 |
| 128 | MP0001881_abnormal_mammary_gland | 0.43429805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 8.29422484 |
| 2 | Recurrent abscess formation (HP:0002722) | 8.22061513 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.68490793 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 7.65152359 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 6.20702908 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.79487022 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.92719272 |
| 8 | Recurrent skin infections (HP:0001581) | 4.87791865 |
| 9 | Gingivitis (HP:0000230) | 4.86506268 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.20584336 |
| 11 | Obstructive lung disease (HP:0006536) | 4.20584336 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.19289709 |
| 13 | Stomatitis (HP:0010280) | 4.18154897 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 4.05551370 |
| 15 | Neurofibrillary tangles (HP:0002185) | 4.03114319 |
| 16 | Optic neuritis (HP:0100653) | 3.90102528 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.90102528 |
| 18 | Orchitis (HP:0100796) | 3.86767097 |
| 19 | Axonal loss (HP:0003447) | 3.85364629 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.78850757 |
| 21 | Myositis (HP:0100614) | 3.77002434 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.69564858 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.69564858 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.69564858 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.66002199 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.66002199 |
| 27 | Increased IgM level (HP:0003496) | 3.63692484 |
| 28 | Disinhibition (HP:0000734) | 3.61815434 |
| 29 | Increased cerebral lipofuscin (HP:0011813) | 3.60259554 |
| 30 | Mucopolysacchariduria (HP:0008155) | 3.58021155 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.58021155 |
| 32 | Basal ganglia calcification (HP:0002135) | 3.53971784 |
| 33 | Vasculitis (HP:0002633) | 3.52582807 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 3.51857336 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 3.51453839 |
| 36 | Apathy (HP:0000741) | 3.49277743 |
| 37 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.47561165 |
| 38 | Diminished motivation (HP:0000745) | 3.47336632 |
| 39 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.36756324 |
| 40 | Cellulitis (HP:0100658) | 3.28115386 |
| 41 | Metaphyseal irregularity (HP:0003025) | 3.27266196 |
| 42 | Mutism (HP:0002300) | 3.25227133 |
| 43 | Prostate neoplasm (HP:0100787) | 3.22145348 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 3.18637607 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.18637607 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.18637607 |
| 47 | Recurrent viral infections (HP:0004429) | 3.18262707 |
| 48 | Thick nail (HP:0001805) | 3.16483841 |
| 49 | Interstitial pulmonary disease (HP:0006530) | 3.03778986 |
| 50 | Hemoptysis (HP:0002105) | 2.96511038 |
| 51 | Periodontitis (HP:0000704) | 2.96239027 |
| 52 | Pustule (HP:0200039) | 2.94182421 |
| 53 | Cerebral inclusion bodies (HP:0100314) | 2.93308529 |
| 54 | Xanthomatosis (HP:0000991) | 2.92201240 |
| 55 | Urticaria (HP:0001025) | 2.92108955 |
| 56 | Recurrent pneumonia (HP:0006532) | 2.91841958 |
| 57 | Abnormality of the periventricular white matter (HP:0002518) | 2.88667951 |
| 58 | Pulmonary infiltrates (HP:0002113) | 2.86677610 |
| 59 | Protuberant abdomen (HP:0001538) | 2.80254496 |
| 60 | Agnosia (HP:0010524) | 2.73260152 |
| 61 | Meningitis (HP:0001287) | 2.66798554 |
| 62 | Joint hemorrhage (HP:0005261) | 2.60335214 |
| 63 | Osteomyelitis (HP:0002754) | 2.60171517 |
| 64 | Neuronal loss in central nervous system (HP:0002529) | 2.54283837 |
| 65 | Nuclear cataract (HP:0100018) | 2.54206624 |
| 66 | Poor head control (HP:0002421) | 2.51387809 |
| 67 | Glomerulonephritis (HP:0000099) | 2.48626731 |
| 68 | Skin nodule (HP:0200036) | 2.47440801 |
| 69 | Gangrene (HP:0100758) | 2.47380383 |
| 70 | Recurrent lower respiratory tract infections (HP:0002783) | 2.46534051 |
| 71 | Global brain atrophy (HP:0002283) | 2.45149593 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.44434181 |
| 73 | Multiple enchondromatosis (HP:0005701) | 2.42729428 |
| 74 | Tetraparesis (HP:0002273) | 2.41912883 |
| 75 | Arterial thrombosis (HP:0004420) | 2.41055565 |
| 76 | Hepatosplenomegaly (HP:0001433) | 2.40992396 |
| 77 | Cheilitis (HP:0100825) | 2.40341972 |
| 78 | Premature loss of primary teeth (HP:0006323) | 2.38033556 |
| 79 | Myocardial infarction (HP:0001658) | 2.37175322 |
| 80 | Gingival bleeding (HP:0000225) | 2.35757888 |
| 81 | Asymmetric septal hypertrophy (HP:0001670) | 2.34103237 |
| 82 | Epidermoid cyst (HP:0200040) | 2.32094012 |
| 83 | Leukocytosis (HP:0001974) | 2.28904146 |
| 84 | Progressive neurologic deterioration (HP:0002344) | 2.26881016 |
| 85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.25022958 |
| 86 | Dementia (HP:0000726) | 2.20625776 |
| 87 | Abnormality of T cell number (HP:0011839) | 2.20403186 |
| 88 | Upper motor neuron abnormality (HP:0002127) | 2.19991048 |
| 89 | Paralysis (HP:0003470) | 2.19617376 |
| 90 | Increased CSF protein (HP:0002922) | 2.18948869 |
| 91 | Keratoconjunctivitis sicca (HP:0001097) | 2.16556424 |
| 92 | Sepsis (HP:0100806) | 2.15922962 |
| 93 | Anorexia (HP:0002039) | 2.14411088 |
| 94 | Personality changes (HP:0000751) | 2.11294440 |
| 95 | J-shaped sella turcica (HP:0002680) | 2.09652069 |
| 96 | Cardiomegaly (HP:0001640) | 2.09108636 |
| 97 | Retinal atrophy (HP:0001105) | 2.08976925 |
| 98 | Dysostosis multiplex (HP:0000943) | 2.08518862 |
| 99 | Abnormality of the pericardium (HP:0001697) | 2.08324375 |
| 100 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.08236444 |
| 101 | Prolonged neonatal jaundice (HP:0006579) | 2.06663794 |
| 102 | Petechiae (HP:0000967) | 2.05181652 |
| 103 | Nausea (HP:0002018) | 2.01772788 |
| 104 | Supranuclear gaze palsy (HP:0000605) | 2.00512754 |
| 105 | Arthralgia (HP:0002829) | 2.00257988 |
| 106 | Joint swelling (HP:0001386) | 1.99148230 |
| 107 | Bone pain (HP:0002653) | 1.97956798 |
| 108 | Purpura (HP:0000979) | 1.97513128 |
| 109 | Keratoconjunctivitis (HP:0001096) | 1.96930589 |
| 110 | Increased serum ferritin (HP:0003281) | 1.96907317 |
| 111 | Neoplasm of head and neck (HP:0012288) | 1.96876419 |
| 112 | Esophageal neoplasm (HP:0100751) | 1.96876419 |
| 113 | Inappropriate behavior (HP:0000719) | 1.96010292 |
| 114 | Thoracic kyphosis (HP:0002942) | 1.94891183 |
| 115 | T lymphocytopenia (HP:0005403) | 1.93702413 |
| 116 | Generalized aminoaciduria (HP:0002909) | 1.92323263 |
| 117 | Porencephaly (HP:0002132) | 1.90769919 |
| 118 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90589904 |
| 119 | Skin ulcer (HP:0200042) | 1.90108584 |
| 120 | Multiple lipomas (HP:0001012) | 1.88409783 |
| 121 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.86149625 |
| 122 | Hypercholesterolemia (HP:0003124) | 1.85799777 |
| 123 | Hyperventilation (HP:0002883) | 1.85344255 |
| 124 | Parakeratosis (HP:0001036) | 1.85021398 |
| 125 | Nephritis (HP:0000123) | 1.84854994 |
| 126 | Amaurosis fugax (HP:0100576) | 1.84496087 |
| 127 | Pathologic fracture (HP:0002756) | 1.82758717 |
| 128 | Thin bony cortex (HP:0002753) | 1.82576517 |
| 129 | Abnormality of the prostate (HP:0008775) | 1.81760197 |
| 130 | Abnormality of the pleura (HP:0002103) | 1.81330371 |
| 131 | Esophageal varix (HP:0002040) | 1.79667960 |
| 132 | Progressive visual loss (HP:0000529) | 1.77542079 |
| 133 | Chest pain (HP:0100749) | 1.77185873 |
| 134 | Abnormality of the endocardium (HP:0004306) | 1.76802848 |
| 135 | Gastrointestinal stroma tumor (HP:0100723) | 1.76101159 |
| 136 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.76096878 |
| 137 | Osteolytic defects of the hand bones (HP:0009699) | 1.76096878 |
| 138 | Loss of speech (HP:0002371) | 1.72757381 |
| 139 | Peripheral demyelination (HP:0011096) | 1.70650173 |
| 140 | Autoimmune hemolytic anemia (HP:0001890) | 1.70042297 |
| 141 | Abnormality of the lumbar spine (HP:0100712) | 1.68742284 |
| 142 | Spinal muscular atrophy (HP:0007269) | 1.66267658 |
| 143 | Peripheral hypomyelination (HP:0007182) | 1.64611396 |
| 144 | Steatorrhea (HP:0002570) | 1.63176245 |
| 145 | Distal lower limb muscle weakness (HP:0009053) | 1.57656890 |
| 146 | Ovoid vertebral bodies (HP:0003300) | 1.56449459 |
| 147 | Hypophosphatemia (HP:0002148) | 1.55235562 |
| 148 | Vertebral compression fractures (HP:0002953) | 1.54697219 |
| 149 | Abnormality of iron homeostasis (HP:0011031) | 1.53309085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.88594464 |
| 2 | PBK | 5.85958151 |
| 3 | BLK | 4.31588383 |
| 4 | MAP3K14 | 4.28533608 |
| 5 | TBK1 | 3.30714732 |
| 6 | IRAK4 | 2.89905402 |
| 7 | PDK2 | 2.86453942 |
| 8 | ACVR1B | 2.63210133 |
| 9 | TYK2 | 2.62371269 |
| 10 | JAK3 | 2.48447726 |
| 11 | IRAK3 | 2.39917650 |
| 12 | CAMKK2 | 2.38967653 |
| 13 | IKBKB | 2.29505145 |
| 14 | CAMK1D | 2.18095970 |
| 15 | PIM2 | 2.11918925 |
| 16 | NME2 | 2.08258711 |
| 17 | TXK | 1.88033122 |
| 18 | JAK1 | 1.80150519 |
| 19 | MST1R | 1.77729441 |
| 20 | IKBKE | 1.76491102 |
| 21 | MAP4K1 | 1.73357768 |
| 22 | NEK9 | 1.66907837 |
| 23 | LIMK1 | 1.64435762 |
| 24 | DDR2 | 1.62575858 |
| 25 | MAP2K3 | 1.59204377 |
| 26 | TAOK2 | 1.58774622 |
| 27 | MAP3K3 | 1.57562187 |
| 28 | ABL2 | 1.57512059 |
| 29 | BMX | 1.52325592 |
| 30 | MST4 | 1.50030071 |
| 31 | KIT | 1.49369370 |
| 32 | GRK7 | 1.46719446 |
| 33 | CAMK1G | 1.43903173 |
| 34 | FGR | 1.41202322 |
| 35 | CSK | 1.40658538 |
| 36 | TESK2 | 1.40098044 |
| 37 | SYK | 1.37027548 |
| 38 | BMPR2 | 1.37007479 |
| 39 | CHUK | 1.23699611 |
| 40 | DAPK2 | 1.21202796 |
| 41 | LYN | 1.20018573 |
| 42 | PRPF4B | 1.19650861 |
| 43 | STK4 | 1.19505258 |
| 44 | MATK | 1.19396096 |
| 45 | JAK2 | 1.19314339 |
| 46 | HCK | 1.15586155 |
| 47 | ERBB3 | 1.15101029 |
| 48 | CDC42BPA | 1.10829625 |
| 49 | PAK4 | 1.10033549 |
| 50 | MAP3K13 | 1.08972360 |
| 51 | RPS6KA4 | 1.08759449 |
| 52 | YES1 | 1.07998345 |
| 53 | ADRBK2 | 1.06528914 |
| 54 | ERN1 | 1.04843098 |
| 55 | ZAP70 | 1.02534951 |
| 56 | RPS6KA2 | 1.01637594 |
| 57 | BTK | 1.00870907 |
| 58 | TRPM7 | 0.94440444 |
| 59 | LCK | 0.93634346 |
| 60 | MARK3 | 0.93237281 |
| 61 | PIM1 | 0.89706921 |
| 62 | CSF1R | 0.89368911 |
| 63 | PRKCD | 0.86990162 |
| 64 | ARAF | 0.85486737 |
| 65 | MAPK12 | 0.84215489 |
| 66 | IRAK1 | 0.83297271 |
| 67 | EIF2AK2 | 0.83147257 |
| 68 | TAOK3 | 0.80394867 |
| 69 | IRAK2 | 0.80049714 |
| 70 | TEC | 0.80014474 |
| 71 | EPHB1 | 0.75892602 |
| 72 | SGK3 | 0.73598810 |
| 73 | MAP3K12 | 0.71302550 |
| 74 | TAOK1 | 0.70745824 |
| 75 | RPS6KC1 | 0.70012971 |
| 76 | RPS6KL1 | 0.70012971 |
| 77 | ERBB4 | 0.69191922 |
| 78 | ABL1 | 0.66375551 |
| 79 | CLK1 | 0.66241672 |
| 80 | EPHA3 | 0.65321829 |
| 81 | FGFR3 | 0.61707553 |
| 82 | MAP2K6 | 0.61383070 |
| 83 | EGFR | 0.60954041 |
| 84 | MAP3K8 | 0.58411287 |
| 85 | CAMKK1 | 0.58350844 |
| 86 | PRKCQ | 0.57323123 |
| 87 | CAMK4 | 0.57075243 |
| 88 | MAP3K5 | 0.56570868 |
| 89 | SIK3 | 0.56540545 |
| 90 | MET | 0.55862276 |
| 91 | PRKG2 | 0.55823788 |
| 92 | SIK2 | 0.51802792 |
| 93 | SGK2 | 0.49924859 |
| 94 | RIPK1 | 0.46975765 |
| 95 | TGFBR2 | 0.46108678 |
| 96 | MAP3K11 | 0.44625035 |
| 97 | PDGFRB | 0.43710756 |
| 98 | STK3 | 0.42887645 |
| 99 | KSR1 | 0.42223793 |
| 100 | MAP3K9 | 0.40147486 |
| 101 | MAPK4 | 0.38992422 |
| 102 | GSK3A | 0.38632390 |
| 103 | FES | 0.38151758 |
| 104 | STK24 | 0.36149008 |
| 105 | FGFR4 | 0.36076637 |
| 106 | FYN | 0.35180942 |
| 107 | DAPK3 | 0.33987276 |
| 108 | NEK6 | 0.33165912 |
| 109 | MAPK7 | 0.33125748 |
| 110 | PRKACB | 0.33026970 |
| 111 | PDPK1 | 0.32579892 |
| 112 | MAP3K6 | 0.32398909 |
| 113 | PDK1 | 0.30977226 |
| 114 | MOS | 0.29195538 |
| 115 | ITK | 0.28444393 |
| 116 | STK10 | 0.26942425 |
| 117 | MAP3K1 | 0.23848957 |
| 118 | INSR | 0.23812321 |
| 119 | MUSK | 0.22936847 |
| 120 | IGF1R | 0.22783688 |
| 121 | BMPR1B | 0.22332699 |
| 122 | PRKCE | 0.22202360 |
| 123 | LRRK2 | 0.21207869 |
| 124 | NLK | 0.20800559 |
| 125 | PIK3CG | 0.19945494 |
| 126 | CDK6 | 0.19604898 |
| 127 | KSR2 | 0.18344009 |
| 128 | PRKCH | 0.18269739 |
| 129 | SRC | 0.17919702 |
| 130 | SCYL2 | 0.17372211 |
| 131 | TESK1 | 0.17213341 |
| 132 | MAPKAPK2 | 0.17176566 |
| 133 | TTN | 0.15532466 |
| 134 | PTK6 | 0.13476501 |
| 135 | MAP3K2 | 0.11104893 |
| 136 | RPS6KA6 | 0.10447556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.99105115 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.42558868 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.15622327 |
| 4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.92102186 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.90811107 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.84602018 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.77439113 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.76484655 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.63057256 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.58520476 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.55219476 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.53270425 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.43903747 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.39633285 |
| 15 | Phagosome_Homo sapiens_hsa04145 | 2.28686918 |
| 16 | Asthma_Homo sapiens_hsa05310 | 2.28353423 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.21861069 |
| 18 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.15423521 |
| 19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.12838756 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.04110409 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.03174287 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.91285930 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.91100883 |
| 24 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.90699510 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.87628249 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.82783128 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74397503 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.63432088 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.59290046 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.57189226 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46616866 |
| 32 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.45928256 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43657641 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39639476 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31129084 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24886734 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.24188252 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23999841 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23905005 |
| 40 | Galactose metabolism_Homo sapiens_hsa00052 | 1.19294715 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.19123784 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.16923954 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15282638 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11372287 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10414174 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05528981 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.04823887 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 1.04610158 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01129869 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.98037387 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94378060 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93223857 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92935572 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90429994 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90080139 |
| 56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87086496 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 0.86240115 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 0.79693320 |
| 59 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74829438 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74414426 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.74244510 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73837994 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72184955 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.69647874 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64975922 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61902941 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61521706 |
| 68 | Bladder cancer_Homo sapiens_hsa05219 | 0.59548327 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55562435 |
| 70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53546686 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50873736 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46279908 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.45395726 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44860152 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44508905 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43837020 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42899105 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41665742 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39159413 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38140266 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37499290 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.36601186 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36309619 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34265089 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34077454 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33720708 |
| 87 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.31267669 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29135755 |
| 89 | Proteasome_Homo sapiens_hsa03050 | 0.28230513 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.28168722 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27368247 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27269248 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25252635 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.23451218 |
| 95 | Carbon metabolism_Homo sapiens_hsa01200 | 0.22637589 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21357973 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21107076 |
| 98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.20481436 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.20274774 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.20128621 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.19679798 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19321828 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18962048 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16839578 |
| 105 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.16498847 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.15793621 |
| 107 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.15775107 |
| 108 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.14883676 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.14682414 |
| 110 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.13182191 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.12968309 |
| 112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.11768906 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.10735324 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.08996264 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.07890951 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.06611215 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.05636438 |
| 118 | Histidine metabolism_Homo sapiens_hsa00340 | 0.04796361 |

